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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S67with cellular changes to chondrocytes, an increase in degradative stimuli
and changes to the proteins of the extracellular matrix. It is not known to
what extent these changes occur with age or if they are speciﬁc to diseased
cartilage. Herein, we systematically investigated the changes that occur
with age in mouse cartilage.
Methods: C57/BL (ICRFa) mice have been selectively bred for longevity.
Knee joints were collected (4 mice/group) at 3, 6, 12, 24, 30 months of age.
Histology was performed with sections stained with hematoxylin & eosin
(H&E), safranin O, Picro-sirius red and antibodies to cleaved type II
collagen, MMP13, nitro-tyrosine (as a measure of oxidative stress), cleaved
LC3B (as a measure of autophagy) and Bcl-2 /Bax (as a measure of
apoptosis).
Results: Our data indicate that a progressive degradation and loss of
matrix occurs with age particularly in the load bearing area of cartilage. An
increase in oxidative stress, MMP13 expression and type II collagen
cleavage products occur with age with a concomitant decrease in
autophagy and increase in apoptosis.
Conclusions: This study demonstrates that many of the changes that
occur in osteoarthritis are found in cartilage with increasing age. The
increase in the level of oxidative stress, MMP-13 and type II collagen
cleavage products explain the complete loss of cartilage tissue from
load bearing regions of the joint in 30 month old mice joints. These
changes explain the marked predisposition to osteoarthritis with
increasing age.
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CHANGES INDUCED BY CHRONIC IN VIVO LOAD ALTERATION IN THE
TIBIO-FEMORAL JOINT OF MATURE RABBITS
M. Roemhildt, B. Beynnon, G. Badger, M. Gardner-Morse. Univ. of Vermont,
Burlington, VT
Purpose: This work determines the relationship between the magnitude
and duration of chronic compressive load alteration and the development
of degenerative changes in the rabbit tibio-femoral joint.
Methods: Twenty male skeletally-mature NZW rabbits, 12 months of
age, mean weight 4.460.48 kg were randomized into one of 5
treatment groups: 0% BW-12wk (Sham), 50% BW-12wk, 80% BW-
12wk, 50% BW-24wk, and 80% BW-24wk (n¼4/group). NIH guidelines
for the care and use of animals were observed. A varus loading device
(VLD) was attached to the left hind limb to apply altered compressive
loads of 0, 50 or 80% body weight (BW) to the tibio-femoral joint
resulting in increased loading to the medial compartment and
decreased loading to the lateral compartment. Altered loads were
applied 12 hours per day for 12 or 24 weeks. Compartment-speciﬁc
assessment of the tibial plateau from the experimental limb included
histological assessments (OARSI degeneration score, articular carti-
lage, calciﬁed cartilage, and subchondral bone thicknesses, and
articular cartilage cellularity) and biomechanical measures (aggregate
modulus and permeability). Analyses of variance techniques were
used to examine the relationship between each outcome measure
with load magnitude and duration as independent variables in the
model.
Results: Degenerative changes developed in the medial compartment
with increased magnitude of compressive loading (Fig. 1 & 2). The
mean degeneration score in the 80% BW-24wk group increased 110% as
compared to the 0% BW-12wk (Sham) group and 58% from the 80%
BW-12wk group (p< .01 and p¼ .01; respectively). Similarly the 50%
BW-12wk and 50% BW-24wk groups were increased as compared to
the 0% BW-12wk group (p¼ .04 each). The mean cellularity varied with
time across groups in the medial compartment (p¼ .01). Cellularity of
the 50% BW-24wk group was decreased 22% as compared to the 50%
BW-12wk group (p¼ .03). A similar decrease of 22% was observed for
the 80% BW-24wk group as compared to the 80% BW-12wk group (p¼
.08). Increased calciﬁed cartilage thickness was observed in both the
medial and lateral compartments following exposure to altered
loading of 80% BW for 24 weeks (p< .05 for each). Differences in
aggregate modulus and permeability across groups did not reach
statistical signiﬁcance.ĂFig. 1. Representative sections of the medial compartment stained with
Safranin-O (A-E) and H&E (F-J); * loss of proteoglycan staining, –> chon-
drocyte hypertrophy, # decreased cellularity.
ĂFig. 2. Mean degeneration score and cellularity of the medial and lateral
compartments.
Conclusions: This work demonstrates that in vivo chronic compressive
load alteration applied to the tibio-femoral joint can initiate degenerative
changes as evidenced by increased degenerative scoring and diminished
cellularity analogous to the early changes occurring in OA. These changes
were most pronounced in the medial compartment which experienced an
increase in compressive loading. In this work, histological-basedmetrics of
degeneration detected load-induced alterations prior to signiﬁcant effects
on aggregate modulus and permeability.
The VLD rabbit model may be used to study an important risk factor
associated with primary OA, increased loading. Overall, the combination of
load levels (50 and 80% BW) and load duration (12 and 24 wk) resulted in
histological changes in the medial compartment consistent with early OA,
including cartilage ﬁbrillation, loss of proteoglycan staining, and dimin-
ished cellularity (Fig. 1). Additionally, increased calciﬁed cartilage thick-
ness and focal chondrocyte hypertrophy were observed with increased
compressive loading.
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ANTI-INFLAMMATORY EFFECT OF CHONDROMODULATORS IN
EXPERIMENT
S.G. Radenska-Lopovok, E.S. Tsvetkova, L.N. Denisov, E.L. Nasonov,
G.N. Pleskovskaja. Scientiﬁc Res. Inst. of Rheumatology, Moscow, Russian
Federation
Background. There are a few data about the systemic inﬂuence of drugs,
used in osteoarthritis. A hind limp arthropathy is characterized by
progressive cartilage destruction and develops spontaneously in MRL/Mp-
lpr/lpr (MRL/l) mice. These mice are a good model for assessment of drugs
with chondro-reparitive activity. The aim of our investigationwas to study
healing effect of intramuscular injection (IMJ) of chondroitin sulphate (CS)
on joint cartilage and tissue lesions.
Material and methods. The age of all animals (60 mice - 30males and 30
females) at the experiment beginning was 5 months. Cartilage, heart,
kidney and liver were studied in two groups as follows: the placebo group
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received 3 times per week 25 IMJ of 0,2 ml 10% solution CS. After eutha-
nasia tissues were ﬁxed for 24 hours in 10% neutral buffered formaldehyde.
Kidney, heart and liver were investigated by histological and histochemical
methods. The material was studied by blind method.
Results. At the end of the experiment only 5 males survived in placebo
group, in the CS group - 15males and 10 females. The alive animals were
decapitated. In placebo group ﬁbrocartilage articular surfacewas destroyed
and remodelled. Tide mark was absent. Acid glycosaminoglycanes (GAG)
depletion and collagen network fragmentation have been estimated.
Severe vasculitis in all organs were found. There were severe nephritis,
myocarditis and hepatitis too. In the CS group cartilage was uniform, with
normal thickness and layer differentiation. Cartilage reparation processes
have been estimated as follows - the number of double-nuclear chon-
drocytes increased and accumulated in groups. GAG increased too. Collagen
structure re-established. Tide markwas safe. Dystrophy andmild vasculitis
in heart and liver, severe alteration in kidney were found. There was
signiﬁcant difference between the group results (p<0,05).
Conclusion. Not only cartilage, but organic lesions, such as vasculitis,
nephritis, myocarditis and hepatitis are inﬂuenced after chon-
dromodulators’ treatment of MRL/l mice. These results provide some
insight into the anti-inﬂammatory mechanism of CS action.
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FOLLISTATIN ALLEVIATES SYNOVITIS AND ARTICULAR CARTILAGE
DEGRADATION INDUCED BY CARRAGEENAN IN MICE
K. Tsuji, J. Yamada, K. Miyatake, K. Abula, Y. Matsukura, I. Sekiya,
T. Muneta. Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: Osteoarthritis (OA), a chronic degenerative joint disorder char-
acterized by articular cartilage destruction and osteophyte formation, is
prevalent in our society as a major cause of disability. Molecular patho-
genesis of OA is not fully understood, it is considered that acute joint
inﬂammation plays signiﬁcant roles in the onset of OA. This idea is sup-
ported by various animal experiments, since articular cartilage degradation
is induced by the intra-articular injection of carrageenan or zymosan.
Previously we showed that intra-articular injection of recombinant human
BMP7 (rhBMP7) inhibited cartilage degradation induced by zymosan
partly through the inhibition of inﬂammatory cytokine expression such as
IL1-beta in the joint. From these data we hypothesized that TGF-beta/BMP
signal maintains joint homeostasis by controlling inﬂammatory status.
Here we report that follistatin, an endogenous inhibitor for Activin which
belongs toTGF-beta/BMP family and works as a proinﬂammatory cytokine,
effectively alleviates synovitis and articular cartilage degradation induced
by the intra-articular injection of carrageenan in mice.
Methods: This study was approved and conducted in accordance with the
guideline of the animal committee of Tokyo Medical and Dental University.
Male C57Bl/6J mice (12weeks old) were purchased from ORIENTAL YEAST
co.,Ltd (Tokyo, Japan). They were housed under a 12-h light-dark cycle and
allowed food andwater ad libitum. Twelvemicewere randomly divided into
two groups (n¼6/group). Mice were anesthetized by the inhalation of 5%
isoﬂurane in oxygen. Under deep anesthesia, a solution of 30mg lamda-
carrageenan (Sigma-Aldrich) in 5mL saline was injected into the left knee
joint through the lateral margin of the patella tendon. Recombinant mouse
follistatin (25ng in 5ml in physiological saline, Sigma-Aldrich) was injected
into the left knee at 30 minutes before carrageenan challenge. Mice were
maintained in cage ad libitum for 3 days after the challenge. Knee jointswere
dissected, ﬁxed in 4% paraformaldehyde, decalciﬁed, embedded, and 5mm
sagittal sections were prepared for histology. Integrity of articular cartilage
and synovium was assessed by Hematoxylin and Eosin staining. To assess
articular cartilage damage, three sections (apart from 150mm respectively)
were stained by Safranin O and 400 mm in width of articular cartilage
between anterior and posterior edge ofmedialmeniscuswas contoured into
3 areas according to the dyeability: Grade I; intact cartilage, Grade II; mildly
denatured cartilagewith reduced safranin O staining, and Grade III; severely
denatured cartilage with no Safranin O staining. Each area was measured
using Zeiss Axio Vision Image Analysis system. Kruskal-Wallis test followed
by Tukey-Kramer methods was used for statistical analysis.
Results: Image analyses indicated that dyeability of articular cartilage by
Safranin O was signiﬁcantly reduced by the single intra-articularinjection of carrageenan at 3 days (Grade I: 21.4%, Grade II: 33.8%, Grade
III: 44.8%), although we did not observe any obvious alteration in the
articular surface structure at this stage. In contrast, the loss of dyeability
after carrageenan injection was signiﬁcantly improved by the pre-
injection of follistatin (Grade I: 26.4%, Grade II: 73.6%, Grade III: 0%,
p<0.05). Hematoxylin and Eosin staining showed that the cellularity of
synovial tissue is greatly increased in carrageenan-injected mice. In
contrast, these inﬂammatory responses were greatly alleviated by the
pre-injection of follistatin.
Conclusions: Carrageenan-induced arthritis is a well-established
experimental model to investigate inﬂammation-mediated articular
cartilage degradation in rodents. Here we report that follistatin effec-
tively inhibits the loss of Safranin O dyeability of articular cartilage
induced by carrageenan. Our data strongly suggest that the Activin signal
pathway is involved in the process of joint inﬂammation and proteo-
glycan loss in the cartilage matrix. We believe that our experimental
system will be of great use for analyzing the molecular events under-
going the onset of OA.
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NEW EVIDENCE LINKING THE IN VIVO IMPLICATION OF 4-
HYDROXYNONENAL IN THE OSTEOARTHRITIS PATHOGENESIS.
Q. Shi, H. Fahmi, J.C. Fernandes, M. Benderdour. Univ. of Montreal,
Montreal, QC, Canada
Purpose: To demonstrate the in vivo involvement of 4-hydroxynonenal
(HNE), a major aldehyde derived from lipid peroxidation of n-6 poly-
unsaturated fatty acids, in the osteoarthritis (OA) pathogenesis.
Methods: Protocol 1 - OA was induced by anterior cruciate ligament
transection of the right knee in crossbred dogs. There were two experi-
mental groups (n¼4 dogs/group): placebo and carnosine (an HNE-trapping
drug, 50 mg/kg/day) given orally for 8 weeks Protocol 2 - Vehicle or
pathophysiological dose of HNE (100 mM) were injected weekly into the
right knee joint of crossbred dogs (n¼4 dogs/group) for the entire duration
of the study (16 weeks). We conducted macroscopic and histomorpho-
logical analyses of cartilage of the femoral condyles and/or tibial plateaus.
We also conducted immunohistochemical analyses in cartilage explants
for the following antigens: HNE, agrecannase-2, and matrix metal-
loproteinase -13 (MMP-13).
Results: In the protocol 1, treatment with carnosine reduced the severity
and histopathological score of OA cartilage lesions as well as the levels of
HNE, MMP-13 and agrecannase-2 in cartilage explants. In the protocol 2,
the intraarticular injection of HNE induced cartilage lesions on the tibial
plateaus and femoral condyles with prominent osteophytes on lateral
condyles. The expression of both MMP-13 and agrecannase-2 increased in
cartilage explants from HNE-treated dogs.
Conclusions: This is the ﬁrst in vivo study to demonstrate the patho-
physiological role of HNE in OA. The fact that carnosine abolishes HNE
production and a number of factors known to be involved in OA patho-
genesis renders it a clinically valuable agent in the prevention of this
disease.
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A COLLAGEN-PLATELET COMPOSITE TO STIMULATE HEALING AFTER
ACL SURGERY ALSO MINIMIZES CARTILAGE DAMAGE IN THE ACL
INJURED KNEE
B.C. Fleming 1, J.T. Machan 1, M.R. Shalvoy 1, M.M. Murray 2. 1Alpert Med.
Sch. of Brown Univ., Providence, RI; 2Childrens Hosp. Boston, Boston, MA
Purpose: ACL injury is a risk factor for early post-traumatic osteoarthritis
(PTOA), and the gold standard of treatment, ACL reconstruction, does not
reduce this risk. The mechanism of PTOA in the ACL injured joint is likely
due both to the initial inﬂammation and ongoing subtle mechanical
instability. Recently, intra-articular implantation of a collagen-platelet
composite (CPC) during surgery in animal models has been shown to
improve healing following bio-enhanced ACL repair or ACL reconstruction
procedures, though the impact of the CPC on articular cartilage remains
unknown. We hypothesize that cartilage integrity following bio-enhanced
